Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Invested Capital (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Invested Capital over the past 15 years, most recently at $131.8 million for Q2 2025.

  • Quarterly results put Invested Capital at $131.8 million for Q2 2025, down 3.1% from a year ago — trailing twelve months through May 2025 was $131.8 million (down 3.1% YoY), and the annual figure for FY2025 was $131.8 million, down 3.1%.
  • Invested Capital for Q2 2025 was $131.8 million at Lifecore Biomedical, Inc. \De\, up from $127.2 million in the prior quarter.
  • Over the last five years, Invested Capital for LFCR hit a ceiling of $366.8 million in Q2 2021 and a floor of $75.3 million in Q3 2023.
  • Median Invested Capital over the past 5 years was $135.0 million (2023), compared with a mean of $179.8 million.
  • Biggest five-year swings in Invested Capital: tumbled 57.34% in 2023 and later skyrocketed 68.7% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Invested Capital stood at $279.6 million in 2021, then decreased by 21.99% to $218.1 million in 2022, then tumbled by 56.78% to $94.3 million in 2023, then surged by 34.44% to $126.8 million in 2024, then grew by 3.96% to $131.8 million in 2025.
  • The last three reported values for Invested Capital were $131.8 million (Q2 2025), $127.2 million (Q1 2025), and $126.8 million (Q4 2024) per Business Quant data.